pacira.com - Nilai perusahaan marang pendapatan PCRX

Logo perusahaan publik Pacira Pharmaceuticals (PCRX)

How does the moderate cyclicality of elective surgeries impact the valuation of Pacira BioSciences (PCRX)? The EV/Sales trend displayed on GURU.Markets illustrates the current trajectory, where 2027.92 captures the magnitude of this metric. High-capacity analgesic production facilities ensure stability, while the integration of the EXPAREL platform into hospital protocols as an opioid alternative drives margin growth.

PCRX Pacira Corp: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

Rincian metrik keuangan lan pasar Pacira (PCRX)

- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
Pambiji fundamental perusahaan:Pacira BioSciences - PCRX
Produk seri Pacira Pharmaceuticals

The operational resilience of Pacira BioSciences (PCRX) is based on the stable operation of production facilities for analgesic manufacturing. The EV/Sales ratio, equal to 2027.92, determines the total business value relative to revenue, excluding the impact of debt load. This metric allows for an assessment of sales capitalization efficiency without distortions from leverage. High capacity utilization confirms the fundamental value of the assets. By analyzing the enterprise value to sales chart, an investor can distinguish market volatility from a systemic decline in efficiency.

Analisis pesaing Pacira BioSciences

HLN: Rasio nilai perusahaan marang pendapatan|Kenvue Corp (KVUE) - Rasio nilai perusahaan marang pendapatan|Verona Pharma PLC - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Jyong Biotech Ltd|Multiplikator EV/Sales Ligand Corp|Multiplikator EV/Sales AMRX|Rasio total nilai perusahaan marang pendapatan Perrigo Company plc|Multiplikator EV/Sales ALVO (Alvotech Biopharmaceuticals)|LQDA: Rasio nilai perusahaan marang pendapatan|Galapagos N.V. - Multiplikator EV/Sales|ANIP - Multiplikator EV/Sales|MNKD: Multiplikator EV/Sales|amphastar.com (AMPH) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan ARS Pharmaceuticals Inc|Nilai perusahaan marang pendapatan Theravance Biopharma, Inc. (TBPH)|Nilai perusahaan marang pendapatan AQST (Aquestive Pharma)|SCPH - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales TECX (Tectonic Therapeutic, Inc.)|TNXP - Nilai perusahaan marang pendapatan|China SXT Pharmaceuticals, Inc. - Multiplikator EV/Sales|EPRX - Multiplikator EV/Sales|BHST: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan ENTX (Entera Bio)|Rasio nilai perusahaan marang pendapatan MindWalk (HYFT)|Multiplikator EV/Sales ABVC BioPharma, Inc. (ABVC)|Rasio nilai perusahaan marang pendapatan Cumberland Corp CPIX|QNTM - Nilai perusahaan marang pendapatan|FGEN - Rasio nilai perusahaan marang pendapatan|TELO - Multiplikator EV/Sales|Rani Therapeutics Inc (RANI) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan SNYR|Rasio nilai perusahaan marang pendapatan Rallybio Corp|Rasio nilai perusahaan marang pendapatan LEXX|Multiplikator EV/Sales PULM|PTHL: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales APM (Aptorum Group Ltd)|LYRA - Nilai perusahaan marang pendapatan|Impact BioMedical Inc - Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan TNFA|YCBD (cbdmd.com) - Nilai perusahaan marang pendapatan|painreform.com - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan CYTO|Rasio nilai perusahaan marang pendapatan LIPO|Rasio nilai perusahaan marang pendapatan optinose.com (OPTN)|PIRS (Pieris Pharma) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Procaps Group S.A. PROC|Rasio total nilai perusahaan marang pendapatan petrospharma.com (PTPI)|QLI - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan SLRN (ACELYRIN)|TFF Pharmaceuticals, Inc (TFFP) - Rasio nilai perusahaan marang pendapatan